Adaptive Biotechnologies Corp. (ADPT)
25.55
-0.44
(-1.69%)
USD |
NASDAQ |
Aug 24, 16:00
25.54
-0.01
(-0.04%)
After-Hours: 20:00
Adaptive Biotechnologies Gross Profit Margin (Quarterly) : 70.15% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 70.15% |
| March 31, 2026 | 70.56% |
| December 31, 2025 | 71.37% |
| September 30, 2025 | 77.30% |
| June 30, 2025 | 64.24% |
| March 31, 2025 | 61.66% |
| December 31, 2024 | 57.04% |
| September 30, 2024 | 58.81% |
| June 30, 2024 | 48.83% |
| March 31, 2024 | 50.35% |
| December 31, 2023 | 45.38% |
| September 30, 2023 | 33.78% |
| June 30, 2023 | 51.84% |
| March 31, 2023 | 35.97% |
| December 31, 2022 | 60.37% |
| September 30, 2022 | 57.58% |
| Date | Value |
|---|---|
| June 30, 2022 | 57.82% |
| March 31, 2022 | 52.75% |
| December 31, 2021 | 49.37% |
| September 30, 2021 | 54.02% |
| June 30, 2021 | 64.50% |
| March 31, 2021 | 67.06% |
| December 31, 2020 | 71.60% |
| September 30, 2020 | 68.83% |
| June 30, 2020 | 63.96% |
| March 31, 2020 | 64.62% |
| December 31, 2019 | 66.85% |
| September 30, 2019 | 71.73% |
| June 30, 2019 | 68.00% |
| March 31, 2019 | 51.55% |
| June 30, 2018 | 48.89% |
| March 31, 2018 | 50.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Personalis, Inc. | 21.21% |
| 10X Genomics, Inc. | 74.36% |
| Alamar Biosciences, Inc. (California) | 60.21% |
| Champions Oncology, Inc. | 48.77% |
| Medpace Holdings, Inc. | 27.56% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.53% |
| Return on Assets | -10.33% |
| Return on Invested Capital | -14.26% |
| Profit Margin (Quarterly) | -55.82% |
| Operating Margin (Quarterly) | -21.93% |
| Return on Net Operating Assets | -25.22% |